|
KMID : 1137020150260030232
|
|
Journal of Gynecologic Oncology
2015 Volume.26 No. 3 p.232 ~ p.239
|
|
|
The Korean guideline for cervical cancer screening
|
|
Min Kyung-Jin
Lee Yoon-Jae
Suh Mi-Na
Yoo Chong-Woo
Lim Myong-Cheol
Choi Jae-Kyung
Ki Mo-Ran
Kim Yong-Man
Kim Jae-Weon
Kim Jea-Hoon
Park Eal-Whan
Lee Hoo-Yeon
Lim Seung-Cheoul
Cho Chi-Heum
Hong Sung-Ran
Dang Ji-Yeon
Kim Soo-Young
Kim Yeol
Lee Won-Chul
Lee Jae-Kwan
|
|
|
Abstract
|
|
|
|
The incidence rate of cervical cancer in Korea is still higher than in other developed countries, notwithstanding the national mass-screening program. Furthermore, a new method has been introduced in cervical cancer screening. Therefore, the committee for cervical cancer screening in Korea updated the recommendation statement established in 2002. The new version of the guideline was developed by the committee using evidence-based methods. The committee reviewed the evidence for the benefits and harms of the Papanicolaou test, liquid-based cytology, and human papillomavirus (HPV) testing, and reached conclusions after deliberation. The committee recommends screening for cervical cancer with cytology (Papanicolaou test or liquid-based cytology) every three years in women older than 20 years of age (recommendation A). The cervical cytology combined with HPV test is optionally recommended after taking into consideration individual risk or preference (recommendation C). The current evidence for primary HPV screening is insufficient to assess the benefits and harms of cervical cancer screening (recommendation I). Cervical cancer screening can be terminated at the age of 74 years if more than three consecutive negative cytology reports have been confirmed within 10 years (recommendation D).
|
|
|
KEYWORD
|
|
|
Mass Screening, Papanicolaou Test, Uterine Cervical Neoplasms
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
    
|